摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-propionyl glucosamine

中文名称
——
中文别名
——
英文名称
N-propionyl glucosamine
英文别名
N-propionyl-D-glucosamine;N-[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]propanamide;N-propyl-D-glucosamine;N-propanoyl glucosamine;2-Propionylamino-2-deoxy-D-glucopyranose;2-Deoxy-2-propionamido-D-glucose;2-Propionamido-2-deoxy-D-glucose;N-Propionyl-D-glucopyranosylamin;GlcNPr
N-propionyl glucosamine化学式
CAS
——
化学式
C9H17NO6
mdl
——
分子量
235.237
InChiKey
RTEOJYOKWPEKKN-JOHDSVJWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.2
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    119
  • 氢给体数:
    5
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-propionyl glucosamine 在 deacetylase from Cyclobacterium marinum DSM 745 作用下, 以 aq. phosphate buffer 为溶剂, 反应 12.0h, 生成 2-deoxy-2-amino glucose
    参考文献:
    名称:
    从几丁质中高效选择性地生物催化生产氨基葡萄糖
    摘要:
    N-乙酰氨基葡萄糖(GlcNAc)是地球上最丰富的生物分子之一,可以廉价地从甲壳类动物的主要成分几丁质中获得。
    DOI:
    10.1039/c6gc02910h
  • 作为产物:
    参考文献:
    名称:
    Synthesis of some p-nitrophenyl 2-acylamino-2-deoxy-d-glucosides and their hydrolysis with the β-d-hexosaminidase from Hohenbuehelia serotina
    摘要:
    DOI:
    10.1016/s0008-6215(00)83565-x
点击查看最新优质反应信息

文献信息

  • A chemoenzymatic route to N-acetylglucosamine-1-phosphate analogues: substrate specificity investigations of N-acetylhexosamine 1-kinase
    作者:Li Cai、Wanyi Guan、Motomitsu Kitaoka、Jie Shen、Chengfeng Xia、Wenlan Chen、Peng George Wang
    DOI:10.1039/b904853g
    日期:——
    Reports an efficient chemoenzymatic production of an N-acetylhexosamine 1-phophate analogues library by N-acetylhexosamine 1-kinase (NahK) and describes the respective substrate specificity on this enzyme.
    报告了一种通过N-乙酰氨基己糖1-激酶(NahK)高效化学酶法生产N-乙酰氨基己糖1-磷酸类似物库的方法,并描述了该酶的相应底物特异性。
  • Synthesis and characterization of N-acyl-tetra-O-acyl glucosamine derivatives
    作者:Chi-Hien Dang、Cong-Hao Nguyen、Thanh-Danh Nguyen、Chan Im
    DOI:10.1039/c3ra46007j
    日期:——
    Novel 1,3,4,6-tetra-O-acyl-N-acyl-D-glucosamine derivatives were synthesized from glucosamine hydrochloride (GlcN·HCl) by the acylation with pyridine as a catalyst. A derivative of tetra-O-acetyl glucosamine contained ketoprofen, a non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic effects, was first synthesized. In analysis of the NMR spectra, the ratio of α:β-anomer showed that penta-acyl-D-glucosamine derivatives and N-acetylated glucosamines containing O-acyl groups have been only the α-anomer. Meanwhile, both the intermediates and the glucoconjugate compound of ketoprofen have only the β-anomer.
    利用吡啶作为催化剂,通过酰化反应从葡萄糖胺盐酸盐(GlcN·HCl)合成了新型1,3,4,6-四-O-酰基-N-酰基-D-葡萄糖胺衍生物。首次合成了一种含有酮洛芬的四-O-乙酰基葡萄糖胺衍生物,酮洛芬是一种具有镇痛和退热作用的无菌性抗炎药物(NSAID)。通过NMR谱图分析,α:β-异构体的比例表明,含有O-酰基的五酰基-D-葡萄糖胺衍生物和N-乙酰化的葡萄糖胺均为α-异构体。同时,酮洛芬的中间体和葡萄糖结合物均为β-异构体。
  • [EN] AMPHETAMINE PRODRUGS<br/>[FR] PRO-MÉDICAMENTS À BASE D'AMPHÉTAMINES
    申请人:SHIRE AG
    公开号:WO2014002039A1
    公开(公告)日:2014-01-03
    The present invention relates to amphetamine prodrugs which provide colonic release of amphetamine.
    本发明涉及提供苯丙胺结肠释放的苯丙胺前药。
  • NOVEL TLR4 INHIBITORS FOR THE TREATMENT OF HUMAN INFECTIOUS AND INFLAMMATORY DISORDERS
    申请人:System of Higher Education University of Pittsburgh - of the Commonwealth
    公开号:US20130281395A1
    公开(公告)日:2013-10-24
    The present invention relates to methods of treating infectious, inflammatory and post-traumatic disorders by administering various compounds newly discovered to have TLR4 inhibitory activity. In addition to methods of treatment, the present invention further provides for pharmaceutical compositions comprising said compounds, together with a suitable pharmaceutical carrier. Because TLR4 is the most upstream receptor in the pro-inflammatory LPS signaling cascade, treatments of the invention, which inhibit or antagonize TLR4 action, may avoid the pitfalls associated with other cytokine inhibitors that act further down the pathway and accordingly play a less specific (and perhaps non-critical) role.
    本发明涉及通过给予新发现具有TLR4抑制活性的各种化合物来治疗感染性、炎症性和创伤后疾病的方法。除了治疗方法外,本发明还提供了包括所述化合物在内的药物组合物,以及适当的药物载体。由于TLR4是促炎性LPS信号级联中最上游的受体,本发明的治疗方法可以通过抑制或拮抗TLR4的作用来避免与其他细胞因子抑制剂相关的缺陷,这些细胞因子抑制剂作用于信号通路中较下游的位置,因此起到了不太特异(也许是非关键)的作用。
  • Hydrolytic and transglycosylation reactions of N-acyl modified substrates catalysed by β-N-acetylhexosaminidases
    作者:Pavla Fialová、Lenka Weignerová、Jana Rauvolfová、Věra Přikrylová、Andrea Pišvejcová、Rüdiger Ettrich、Marek Kuzma、Petr Sedmera、Vladimı́r Křen
    DOI:10.1016/j.tet.2003.10.111
    日期:2004.1
    hydrolytic and transglycosylation capabilities of 35 fungal β-N-acetylhexosaminidases with p-nitrophenyl 2-amino-2-deoxy-β-d-glucopyranoside and its four N-acyl derivatives (CHO, COCH2OH, COCH2CH3, COCF3) as substrates were tested. The preparation of four novel p-nitrophenyl disaccharides from these unnatural substrates catalysed by enzymes from Aspergillus oryzae, Penicillium oxalicum and Talaromyces flavus
    35种真菌β- N-乙酰基己糖胺酶与对硝基苯基2-氨基-2-脱氧-β-d-吡喃葡萄糖苷及其4种N-酰基衍生物(CHO,COCH 2 OH,COCH 2 CH 3的水解和转糖基化能力),COCF 3)作为底物进行了测试。的四种新型制备p硝基苯基二糖从由酶催化的这些非天然底物的米曲霉,草酸青霉和踝节菌属菌代表了相当大的扩展糖苷酶的合成潜力。
查看更多